2019
DOI: 10.1002/clc.23238
|View full text |Cite
|
Sign up to set email alerts
|

The prevalence of 30‐day readmission after acute myocardial infarction: A systematic review and meta‐analysis

Abstract: Objective The 30‐day readmission is associated with increased medical costs, which has become an important quality metric in several medical institutions. This current study is aimed at clarifying the prevalence, the underlying risk factors, and reasons of the 30‐day readmission after acute myocardial infarction (AMI). Methods PubMed, Cochrane Library, and EMBASE were systematically searched to identify eligible studies. Random‐effect models were employed to perform pooled analyses. Means and 95% confidence in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
30
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(34 citation statements)
references
References 34 publications
3
30
0
Order By: Relevance
“…Previous studies reported similar 30-d readmission rates for HF [31,32] and AMI [40,41]. A recent meta-analysis reported a pooled readmission rate for AMI of only 12% [42], but our patients were remarkably older; only one of the 14 included studies exclusively considered a population � 65 and found a readmission rate of 22% [43], which is much closer to our estimate (19.2%). Our results are also consistent with reported 30-d readmission rates for COPD (16.5-22.6%) [31,32,44], or DM (14.2-25%) [45][46][47][48].…”
Section: Discussionsupporting
confidence: 83%
“…Previous studies reported similar 30-d readmission rates for HF [31,32] and AMI [40,41]. A recent meta-analysis reported a pooled readmission rate for AMI of only 12% [42], but our patients were remarkably older; only one of the 14 included studies exclusively considered a population � 65 and found a readmission rate of 22% [43], which is much closer to our estimate (19.2%). Our results are also consistent with reported 30-d readmission rates for COPD (16.5-22.6%) [31,32,44], or DM (14.2-25%) [45][46][47][48].…”
Section: Discussionsupporting
confidence: 83%
“…Kidney diseases have been shown to be a risk factor for CVD readmission in patients within 30 days after acute myocardial infarction (AMI) and other diseases [ 16 , 24–26 ]. In the current study, we found that an advanced age, a history of CVD, and a lower albumin level were independently associated with a higher risk of first-year CVD readmission.…”
Section: Discussionmentioning
confidence: 99%
“…Considered variables were retrieved from literature reviews [1][2][3][9][10][11] and selected from the existing database, as well as some that could be derived. The potential predictors of readmission among patients with AMI were gender, diabetes and hypertension comorbidities, anemia with hematocrit < 33 vol%, stage-3 chronic kidney disease with serum creatinine ≥ 2 mg/dL, atrial fibrillation, smoking, and type of myocardial infarction.…”
Section: Potential Predictorsmentioning
confidence: 99%
“…Most existing models were developed in different settings and periods, thus may not be appropriate to be applied in other contexts. Previous studies [1][2][3][9][10][11] have identified that clinical and laboratory parameters, including atrial fibrillation, severity of AMI, and hypertension, confer a higher risk for an early period of cardiovascular admission, whereas smoking and the burden of comorbid non-cardiac illness, including chronic kidney disease, diabetes mellitus, hypertension, anaemia, and pulmonary disease, raises the risk for AMI-related complications in late readmission. These factors may potentially modify the target for future interventions.…”
Section: Introductionmentioning
confidence: 99%